| Literature DB >> 29044784 |
Nima Rajabi1, Marina Auth1, Kathrin R Troelsen1, Martin Pannek2, Dhaval P Bhatt3, Martin Fontenas1, Matthew D Hirschey3, Clemens Steegborn2, Andreas S Madsen1, Christian A Olsen1.
Abstract
The sirtuin enzymes are important regulatory deacylases in a variety of biochemical contexts and may therefore be potential therapeutic targets through either activation or inhibition by small molecules. Here, we describe the discovery of the most potent inhibitor of sirtuin 5 (SIRT5) reported to date. We provide rationalization of the mode of binding by solving co-crystal structures of selected inhibitors in complex with both human and zebrafish SIRT5, which provide insight for future optimization of inhibitors with more "drug-like" properties. Importantly, enzyme kinetic evaluation revealed a slow, tight-binding mechanism of inhibition, which is unprecedented for SIRT5. This is important information when applying inhibitors to probe mechanisms in biology.Entities:
Keywords: deacylases; drug discovery; enzyme inhibitors; posttranslational modifications; sirtuins
Mesh:
Substances:
Year: 2017 PMID: 29044784 PMCID: PMC5814306 DOI: 10.1002/anie.201709050
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336